Our Top 5 Articles on Biotech & Rare Disease

29/02/2016 - 2 minutes

Today is Rare Disease Day 2016. Because it is an important field for Biotech, we went back to review some of our best articles on the topic from the Labiotech archives.

Here are some of our best – in addition to an overview of 7 Rare diseases and who in Biotech is working on them.


Nº 1: Rare Diseases: Still a ‘Blue Ocean’ for Biotechs?


We wanted to get a deeper understanding of what is today considered a Rare Disease, who is acting the field and the reasons for so many Biotech companies to dive into the field.

We had a chat with three key opinion leaders from Europe to get an expert view on the subject: Andrew Weiss, SVP Communication from Actelion, Karen Aiach, the Founder & CEO of Lysogene and Stephane Boissel, the CEO of TxCell.

Nº 2: The French Woman who started a Biotech to Save her Daughter


We interviewed the Founder and CEO of Lysogene from Paris (France).

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!

Support Us

Become a Member